Healthcare

Regenerative Medicine Reinvented: Frédéric Tonglet on convEyXO’s RNA-Enhanced Exosome Therapies & the Future of Treating Degenerative Disease

Frederick Tonglet — CEO of convEyXO

In this forward-thinking Xraised interview, we sit down with Frédéric Tonglet, CEO of convEyXO, a fast-rising biotech company pioneering RNA-enhanced exosome therapeutics to reverse the root causes of degenerative and inflammatory diseases. Leveraging deep expertise in strategy, biotech operations, and therapeutic development, Frédéric shares how convEyXO is redefining regenerative medicine by mimicking the body’s natural healing mechanisms—rather than simply masking symptoms.

Comments

Leave this field empty

I agree that my name and comment may be published after review. My email, if given, stays private. Post comment

No comments yet — be the first to share your thoughts.